NO20053133L - Kjemiske forbindelser. - Google Patents

Kjemiske forbindelser.

Info

Publication number
NO20053133L
NO20053133L NO20053133A NO20053133A NO20053133L NO 20053133 L NO20053133 L NO 20053133L NO 20053133 A NO20053133 A NO 20053133A NO 20053133 A NO20053133 A NO 20053133A NO 20053133 L NO20053133 L NO 20053133L
Authority
NO
Norway
Prior art keywords
formula
optionally substituted
independently selected
chemical connections
tebazolyl
Prior art date
Application number
NO20053133A
Other languages
English (en)
Norwegian (no)
Other versions
NO20053133D0 (no
Inventor
Michael Barry Gravestock
Folkert Reck
Fei Zhou
Nail James Hales
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0227704A external-priority patent/GB0227704D0/en
Priority claimed from GB0310828A external-priority patent/GB0310828D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20053133D0 publication Critical patent/NO20053133D0/no
Publication of NO20053133L publication Critical patent/NO20053133L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20053133A 2002-11-28 2005-06-27 Kjemiske forbindelser. NO20053133L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0227704A GB0227704D0 (en) 2002-11-28 2002-11-28 Chemical compounds
GB0310828A GB0310828D0 (en) 2003-05-10 2003-05-10 Chemical compounds
PCT/GB2003/005091 WO2004048350A2 (en) 2002-11-28 2003-11-24 Oxazolidinones as antibacterial agents

Publications (2)

Publication Number Publication Date
NO20053133D0 NO20053133D0 (no) 2005-06-27
NO20053133L true NO20053133L (no) 2005-07-15

Family

ID=32395888

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053133A NO20053133L (no) 2002-11-28 2005-06-27 Kjemiske forbindelser.

Country Status (12)

Country Link
US (1) US7498350B2 (de)
EP (1) EP1581524A2 (de)
JP (1) JP2006515601A (de)
KR (1) KR20050084010A (de)
AU (1) AU2003285509A1 (de)
BR (1) BR0316690A (de)
CA (1) CA2507628A1 (de)
MX (1) MXPA05005522A (de)
NO (1) NO20053133L (de)
SA (1) SA04250095A (de)
TW (1) TW200533667A (de)
WO (1) WO2004048350A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1649866A (zh) 2002-02-28 2005-08-03 阿斯特拉曾尼卡有限公司 3－环状基－5－(含氮5－元环)甲基－噁唑烷酮衍生物及其作为抗菌药物的用途
CN1653064A (zh) 2002-02-28 2005-08-10 阿斯特拉曾尼卡有限公司 噁唑烷酮衍生物、其制备方法以及包含它们的药用组合物
ATE471937T1 (de) 2003-07-02 2010-07-15 Merck Sharp & Dohme Cyclopropylgruppensubstituierte oxazolidinonantibiotika und derivate davon
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
CA2567929A1 (en) * 2004-05-25 2005-12-08 Astrazeneca Ab 3- {4- (pyridin-3-yl) phenyl} -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents
WO2007023507A2 (en) * 2005-06-20 2007-03-01 Wockhardt Limited Oxazolidinones bearing antimicrobial activity composition and methods of preparation
EP2069339B1 (de) 2006-09-25 2011-05-18 Wockhardt Research Centre Substituierte piperidinophenyloxazolidinone
WO2008069619A1 (en) * 2006-12-08 2008-06-12 Legochem Bioscience Ltd. Novel oxazolidinone derivatives, process for preparing thereof and pharmaceutical composition containing the same
JP5236246B2 (ja) * 2007-10-18 2013-07-17 株式会社クラレ スルホニルハライド誘導体の製造方法
KR101610315B1 (ko) * 2008-09-02 2016-04-07 주식회사 쿠라레 설톤 유도체의 제조방법
RU2659792C1 (ru) 2008-10-10 2018-07-04 Мерк Шарп Энд Домэ Корп. Оксазолидиноны и способ их очистки
MY156354A (en) 2009-02-03 2016-02-15 Merck Sharp & Dohme Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
US8580767B2 (en) 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
KR101128029B1 (ko) 2010-03-08 2012-03-29 주식회사 레고켐 바이오사이언스 (ｒ)-3-(3-플루오로-4-(1-메틸-5,6-다이하이드로-1,2,4-트리아진-4(1ｈ)-일)페닐)-5-(치환된 메틸)옥사졸리딘-2-온 유도체의 제조방법
FR2975990B1 (fr) 2011-06-01 2013-05-24 Rhodia Operations Procede de preparation d'un compose organique fluore
TW201524956A (zh) * 2013-11-12 2015-07-01 Dow Agrosciences Llc 用於氟化化合物之過程（二）
BR102014028162A2 (pt) 2013-11-12 2015-09-08 Dow Agrosciences Llc processo para fluoração de compostos
TW201609651A (zh) 2013-11-12 2016-03-16 陶氏農業科學公司 用於氟化化合物之過程（一）
KR101561964B1 (ko) 2013-11-15 2015-10-20 한국과학기술연구원 옥사졸리디논 화합물 및 이를 포함하는 c형 간염 예방 또는 치료용 약학 조성물
WO2016061772A1 (en) 2014-10-22 2016-04-28 Merck Sharp & Dohme Corp. Nargenicin compounds and uses thereof as antibacterial agents
TWI726900B (zh) 2015-08-04 2021-05-11 美商陶氏農業科學公司 用於氟化化合物之過程
KR101855334B1 (ko) * 2015-12-11 2018-06-08 에스티팜 주식회사 옥사졸리디논 유도체의 중간체 제조방법
US11452719B2 (en) 2017-12-13 2022-09-27 Merck Sharp & Dohme Llc Pharmaceutical compositions of tedizolid phosphate
AU2019231721B2 (en) * 2018-03-07 2024-06-27 Tisento Therapeutics Inc. Process for preparing soluble guanylate cyclase stimulators
CA3183397A1 (en) 2020-06-18 2021-12-23 Daryl C. Drummond Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
AU5889701A (en) * 2000-06-05 2001-12-17 Dong A Pharm Co Ltd Novel oxazolidinone derivatives and a process for the preparation thereof
US20020115669A1 (en) * 2000-08-31 2002-08-22 Wiedeman Paul E. Oxazolidinone chemotherapeutic agents
DE60212959T2 (de) 2001-04-07 2007-02-15 Astrazeneca Ab Eine sulfonimid-gruppe enthaltende oxazolidinone als antibiotika
SI1427711T1 (sl) * 2001-09-11 2005-12-31 Astrazeneca Ab Oksazolidinonski in/ali izoksazolinski derivati kot antibakterijska sredstva
GB2396350A (en) * 2001-10-25 2004-06-23 Astrazeneca Ab Aryl substituted oxazolidinones with antibacterial activity
CN1649866A (zh) * 2002-02-28 2005-08-03 阿斯特拉曾尼卡有限公司 3－环状基－5－(含氮5－元环)甲基－噁唑烷酮衍生物及其作为抗菌药物的用途
CN1653064A (zh) * 2002-02-28 2005-08-10 阿斯特拉曾尼卡有限公司 噁唑烷酮衍生物、其制备方法以及包含它们的药用组合物
MXPA05005651A (es) 2002-11-28 2005-07-27 Astrazeneca Ab Derivados de oxazolidinona y/o isoxazolina como agentes antibacterianos.
GB0227701D0 (en) 2002-11-28 2003-01-08 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
TW200533667A (en) 2005-10-16
CA2507628A1 (en) 2004-06-10
WO2004048350A3 (en) 2004-10-21
MXPA05005522A (es) 2005-07-25
JP2006515601A (ja) 2006-06-01
SA04250095A (ar) 2005-12-03
EP1581524A2 (de) 2005-10-05
BR0316690A (pt) 2005-10-18
AU2003285509A1 (en) 2004-06-18
US7498350B2 (en) 2009-03-03
US20060116386A1 (en) 2006-06-01
WO2004048350A2 (en) 2004-06-10
NO20053133D0 (no) 2005-06-27
KR20050084010A (ko) 2005-08-26

Similar Documents

Publication Publication Date Title
NO20053133L (no) Kjemiske forbindelser.
NO20052534L (no) Oksazolidinon- og/eller isokazolinderivater som antibakterielle stoffer
NO2015020I2 (no) Ceritinib eller et farmasøytisk akseptabelt salt derav
DK0958296T3 (da) Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme
NO20073926L (no) Pyrazolforbindelser som modulerer aktivitet av CDK-, GSK- og aurorakinaser
NO20073960L (no) Pyrazolderivater for inhibering av CDK og GSK
ATE241617T1 (de) Pyrimidinverbindungen
NO20051165L (no) Benzotiazolderivater som har -adrenoerseptorantagonist aktivitet
NO20052038L (no) Ny adeninforbindelse og anvendelse derav
EA200601235A1 (ru) Производные тиазола
NO20085169L (no) Krystallinske solvater og komplekser av (1S)-1,5-anhydro-L-C- (3-((fenyl)metyl)fenyl)-D-glucitol derivater med aminosyrer som SGLT2-inhibitorer for behandling av diabetes
NO20083520L (no) Tricykliske N-heteroaryl-karboksamidderivater inneholdende en benzimidazolenhet, fremgangsmate for fremstilling av samme og deres terapeutiske anvendelser
CY1106358T1 (el) Νεοι δικυκλικοι αναστολεις της ορμονοευαισθητης λιπασης
NO20072753L (no) 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer
NO20063549L (no) (3-okso-3,4-dihydro-quinoksalin-2-yl-amino)-Benzamidderivater og relatert forbindelse som glykogenfosforylaseinhibitorer for behandling av diabetes og fedme
NO20065012L (no) Tetrahydronaftyridin-derivater og fremgangsmate for fremstilling av disse
NO20022124L (no) Imidazopyridinderivater som fosfodiesterase VII-inhibitorer
NO20070157L (no) Substituerte diketopiperaziner som oksytocinantagonister
NZ516100A (en) Streptogramin derivatives, preparation and compositions containing them
NO20043951L (no) 3-cyklyl-5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
TW200510361A (en) Process of preparating 3-acylaminobenzofuran-2-carboxylic acid derivatives
NO960441L (no) Benzopyraner og farmasöytiske forbindelser inneholdende dem
NO20070972L (no) Benzyloksyderivater som MAOB-inhibitorer
NZ517315A (en) New derivatives of A-500359

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application